#ASCyto16 - Twitter Hashtag

Healthcare Hashtag Project @healthhashtags

almost 10 years ago

Top Influencers of #ascyto16: @marenwhymd @bfaquin @dianaestherossi @cytopathology @roseanniwu @cebumd More 📊: https://t.co/yD47kCBoZn

0

1

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Bethesda & Milan reporting system authors will be donating their royalties to the ASC Foundation 👏👏👏 #ASCyto16 #ASC2016 @cytopathology

0

18

7

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Diagnosis of Medullary TC: measuring calcitonin in FNA washout fluid is very helpful & cheap! -Dr Pusztaszeri #ASCyto16 #ASC2016 #cytopath

marenwhymd's tweet photo. Diagnosis of Medullary TC: measuring calcitonin in FNA washout fluid is very helpful & cheap! -Dr Pusztaszeri #ASCyto16 #ASC2016 #cytopath https://t.co/1B8kykvaMA

0

10

7

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Coming to the next Bethesda: more PTC variants - Dr Pusztaszeri #ASCyto16 #ASC2016 #cytopath #entpath

0

11

14

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

How to deal with NIFTP? Dr Pusztaszeri recommends a recent paper by Krane at al https://t.co/VCDItC68mB #ASCyto16 #ASC2016 #cytopath

marenwhymd's tweet photo. How to deal with NIFTP? Dr Pusztaszeri recommends a recent paper by Krane at al https://t.co/VCDItC68mB #ASCyto16 #ASC2016 #cytopath https://t.co/FAl6w2mQFD

0

17

13

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Mgmt for AUS/FLUS: can do molecular but not required, integrated approach is key! -@DianaEstherossi #ASCyto16 #ASC2016 #cytopath #entpath

marenwhymd's tweet photo. Mgmt for AUS/FLUS: can do molecular but not required, integrated approach is key! -@DianaEstherossi #ASCyto16 #ASC2016 #cytopath #entpath https://t.co/bDIBkVQkFB

0

12

10

1

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

The future of adequacy from @DianaEstherossi - clarification of interim before repeat FNA & preparation method #ASCyto16 #ASC2016 #cytopath

marenwhymd's tweet photo. The future of adequacy from @DianaEstherossi - clarification of interim before repeat FNA & preparation method #ASCyto16 #ASC2016 #cytopath https://t.co/e8VX9f6jRX

0

5

3

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

ATA recommendations for follow up of patients with non diagnostic FNAs -@DianaEstherossi #ASCyto16 #ASC2016 #cytopath

0

12

10

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Great reminder of the non diagnostic Bethesda category-@DianaEstherossi #ASCyto16 #ASC2016 #cytopath

0

4

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Some good news about NIFTP FNA -@bfaquin #ASCyto16 #ASC2016 #cytopath #entpath #niftp

0

9

6

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Some changes based on new NIFTP entity -@bfaquin #ASCyto16 #ASC2016 #cytopath #entpath

0

7

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

NIFTP molecular: NO BRAF V600E but otherwise nonspecific -@bfaquin #ASCyto16 #ASC2016 #cytopath #entpath

0

13

10

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

#NIFTP!! Cannot be accurately distinguished by FNA➡️some skewing, but practically indistinguishable -@bfaquin #ASCyto16 #ASC2016 #cytopath

marenwhymd's tweet photo. #NIFTP!! Cannot be accurately distinguished by FNA➡️some skewing, but practically indistinguishable -@bfaquin #ASCyto16 #ASC2016 #cytopath https://t.co/W1NzpHpFlA

0

16

14

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

On ROM: true risk somewhere in between, may need to be institution-specific -@bfaquin #ASCyto16 #ASC2016 #cytopath #endopath

0

4

5

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Our expert panelists: @bfaquin, Dr Marc Pusztaszeri, & Dr Ester Diana Rossi #ASCyto16 #ASC2016 #cytopath #entpath #thyroid

1

8

7

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Molecular tests should always be done in tandem with cytology interpretation-Dr Ali #ASCyto16 #ASC2016 #cytopath

0

11

8

1

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Success of the Bethesda system! "A truly successful endeavor" -Dr Ali #ASCyto16 #ASC2016 #cytopath

0

3

5

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Most contentious in thyroid FNA: "cyst fluid only" does have some risk of cystic PTC, most call unsat -Dr Ali #ASCyto16 #ASC2016 #cytopath

marenwhymd's tweet photo. Most contentious in thyroid FNA: "cyst fluid only" does have some risk of cystic PTC, most call unsat -Dr Ali #ASCyto16 #ASC2016 #cytopath https://t.co/7Af24ZhQek

1

9

6

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Risk of malignancy with thyroid FNA dx: due for some updates in next Bethesda -Dr Ali #ASCyto16 #ASC2016 #cytopath

0

3

7

0

Maren Y. Fuller is not here @marenwhymd

almost 10 years ago

Now the JASC sponsored session on Thyroid Bethesda update (& submit to JASC!) #ASCyto16 #ASC2016 #cytopath @cytopathology

0

9

5

0

Top Tweets for #ASCyto16

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users